Vicarious Surgical Inc. (RBOT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Vicarious Surgical Inc. (RBOT) has a cash flow conversion efficiency ratio of -1.772x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-6.33 Million) by net assets ($3.57 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see RBOT stock market capitalisation for the company's overall valuation and market capitalisation.
Vicarious Surgical Inc. - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Vicarious Surgical Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Vicarious Surgical Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Vicarious Surgical Inc. ranked by their cash flow conversion efficiency. Explore earnings quality score of Vicarious Surgical Inc. to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
OVATION SCIENCE I
F:0VH
|
N/A |
|
Artisanal Spirits Company PLC
LSE:ART
|
-0.155x |
|
Rua Life Sciences PLC
LSE:RUA
|
0.004x |
|
Eden Research plc
LSE:EDEN
|
-0.048x |
|
Premier Health of America Inc
V:PHA
|
-0.010x |
|
Zinc Media Group
LSE:ZIN
|
0.066x |
|
Manolete Partners PLC
LSE:MANO
|
0.081x |
|
CARLYLE COMMODIT.CORP.
F:BJ4
|
-0.183x |
Annual Cash Flow Conversion Efficiency for Vicarious Surgical Inc. (2019–2025)
The table below shows the annual cash flow conversion efficiency of Vicarious Surgical Inc. from 2019 to 2025. View Vicarious Surgical Inc. (RBOT) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $9.84 Million | $-45.08 Million | -4.580x | -328.17% |
| 2024-12-31 | $46.70 Million | $-49.96 Million | -1.070x | -68.21% |
| 2023-12-31 | $97.97 Million | $-62.30 Million | -0.636x | -15.37% |
| 2022-12-31 | $111.05 Million | $-61.21 Million | -0.551x | -37.55% |
| 2021-12-31 | $83.09 Million | $-33.30 Million | -0.401x | +43.90% |
| 2020-12-31 | $16.85 Million | $-12.04 Million | -0.714x | -28.18% |
| 2019-12-31 | $15.63 Million | $-8.71 Million | -0.557x | -- |
About Vicarious Surgical Inc.
Vicarious Surgical Inc. engages in the development and sale of single-port surgical robot in the United States. The company offers Vicarious Surgical System, a single-port surgical robot that virtually transports surgeons inside the patient to perform invasive surgery. Vicarious Surgical Inc. was founded in 2014 and is headquartered in Waltham, Massachusetts.